Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Thouvenot

Showing results (81-90 of 145) with videos related to

Pageof 15
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 2, 2024
Association between education level and access to disease-modifying treatment in patients with multiple sclerosis in FranceMathilde Lefort, Olivier Dejardin, Eric Berger, et al.
Annals of Clinical and Translational Neurology|August 8, 2025
Durable B-Cell Impairment While Sparing IgA B Cells After Ocrelizumab Therapy in Multiple SclerosisAlexandra Garcia, Stephane Rodriguez, Emilie Dugast, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 22, 2023
Immune Profiling Reveals the T-Cell Effect of Ocrelizumab in Early Relapsing-Remitting Multiple SclerosisAlexandra Garcia, Emilie Dugast, Sita Shah, et al.
Annals of Clinical and Translational Neurology|April 8, 2021
Comparison of Simoa<sup>TM</sup> and Ella<sup>TM</sup> to assess serum neurofilament-light chain in multiple sclerosisAudrey Gauthier, Sébastien Viel, Magali Perret, et al.
Neurology|October 12, 2023
Comparison of 2 Methods for Estimating Multiple Sclerosis-Related MortalityFabien Rollot, Zoé Uhry, Emmanuelle Dantony, et al.
Journal of Neurology|February 14, 2019
Correction to: Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adultsAlvaro Cobo-Calvo, María Sepúlveda, Hyacintha d'Indy, et al.
Neurology|May 22, 2026
French NOMADMUS Cohort Overview: Landscape Evolution of AQP4+NMOSD and MOGAD From 2010 to 2024Thomas Roux, François-Xavier Lejeune, Romain Casey, et al.
Archives of Neurology|July 11, 2012
Long-term outcomes of CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids) in a consecutive series of 12 patientsGuillaume Taieb, Claire Duflos, Dimitri Renard, et al.
Journal of Neurology|January 5, 2019
Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adultsAlvaro Cobo-Calvo, María Sepúlveda, Hyacintha d'Indy, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 17, 2022
One-month humoral response following two or three doses of messenger RNA coronavirus disease 2019 vaccines as primary vaccination in specific populations in France: first results from the Agence Nationale Recherche contre le Sida (ANRS)0001S COV-POPART cohortPaul Loubet, Linda Wittkop, Laetitia Ninove, et al.
Pageof 15

Showing results (81-90 of 145) with videos related to

Sort By:
Pageof 15
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 2, 2024
Association between education level and access to disease-modifying treatment in patients with multiple sclerosis in FranceMathilde Lefort, Olivier Dejardin, Eric Berger, et al.
Annals of Clinical and Translational Neurology|August 8, 2025
Durable B-Cell Impairment While Sparing IgA B Cells After Ocrelizumab Therapy in Multiple SclerosisAlexandra Garcia, Stephane Rodriguez, Emilie Dugast, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 22, 2023
Immune Profiling Reveals the T-Cell Effect of Ocrelizumab in Early Relapsing-Remitting Multiple SclerosisAlexandra Garcia, Emilie Dugast, Sita Shah, et al.
Annals of Clinical and Translational Neurology|April 8, 2021
Comparison of Simoa<sup>TM</sup> and Ella<sup>TM</sup> to assess serum neurofilament-light chain in multiple sclerosisAudrey Gauthier, Sébastien Viel, Magali Perret, et al.
Neurology|October 12, 2023
Comparison of 2 Methods for Estimating Multiple Sclerosis-Related MortalityFabien Rollot, Zoé Uhry, Emmanuelle Dantony, et al.
Journal of Neurology|February 14, 2019
Correction to: Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adultsAlvaro Cobo-Calvo, María Sepúlveda, Hyacintha d'Indy, et al.
Neurology|May 22, 2026
French NOMADMUS Cohort Overview: Landscape Evolution of AQP4+NMOSD and MOGAD From 2010 to 2024Thomas Roux, François-Xavier Lejeune, Romain Casey, et al.
Archives of Neurology|July 11, 2012
Long-term outcomes of CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids) in a consecutive series of 12 patientsGuillaume Taieb, Claire Duflos, Dimitri Renard, et al.
Journal of Neurology|January 5, 2019
Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adultsAlvaro Cobo-Calvo, María Sepúlveda, Hyacintha d'Indy, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 17, 2022
One-month humoral response following two or three doses of messenger RNA coronavirus disease 2019 vaccines as primary vaccination in specific populations in France: first results from the Agence Nationale Recherche contre le Sida (ANRS)0001S COV-POPART cohortPaul Loubet, Linda Wittkop, Laetitia Ninove, et al.
Pageof 15